About
Leviticus Cardio is developing a wireless system capable of providing the day-to-day power needs for implanted ventricular assist devices (VADs) while eliminating the complications related to the drive line. The companys solution uses a proprietary technology called Coplanar Energy Transfer (CET), which can work with all available commercial VADs. CET uses a receiver coil implanted next to the VAD device and an external transmitter coil worn around the chest, with both coils in the same plane. The transmitter coil encircles the receiver coil and inductively transfers electromagnetic power to it from all directions. The CET system can supply up to 30 watts at between 80% and 90% efficiency. Leviticus Cardio performed system integration of its CET technology with four commercial VADs and tested the solution in vitro and in vivo. These tests showed reliable energy transfer and pump operation for long periods of time.
Funding history · 3 rounds · $5.8M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the current operational status of Leviticus Cardio?
- Leviticus Cardio is currently inactive, having ceased operations in March 2026.
- When was Leviticus Cardio founded and what is its primary focus?
- Leviticus Cardio was founded in February 2008 and focuses on developing a wireless system for powering implanted ventricular assist devices (VADs).
- What is the total amount of funding Leviticus Cardio has raised?
- Leviticus Cardio has raised a total of $5,770,000 USD across various funding rounds. For a full financing history, please refer to startupim.
- Which investor participated in Leviticus Cardio's Seed round?
- In October 2013, The Trendlines Group invested in Leviticus Cardio's Seed round.
- Has Leviticus Cardio received any grants?
- Yes, Leviticus Cardio received a grant of $1,600,000 USD from the IIA in December 2016 and another $570,000 USD from the IIA in January 2019.
- When was the first human implantation of Leviticus Cardio's wireless heart pump technology reported?
- In February 2019, news reports indicated that Leviticus Cardio's wireless heart pump technology was implanted in a patient for the first time.
- Did Leviticus Cardio receive a grant in collaboration with Jarvik Heart?
- Yes, in January 2019, Leviticus Cardio and Jarvik Heart were awarded an R&D grant from the BIRD Foundation.
- What was a significant achievement reported by Leviticus Cardio in December 2018?
- In December 2018, Leviticus Cardio announced the successful completion of a groundbreaking six-month chronic animal study.
- What is the core technology developed by Leviticus Cardio?
- Leviticus Cardio developed a proprietary technology called Coplanar Energy Transfer (CET) for wireless power delivery to VADs, capable of supplying up to 30 watts at 80-90% efficiency.